Mayne Pharma | MYX - Ebitda

Stock Price
2.70
Daily Change
-0.03 -1.10%
Monthly
-14.01%
Yearly
-41.81%
Q1 Forecast
2.74

Mayne Pharma reported AUD20.9M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Ansell USD 192.8M 28.7M Jun/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Cochlear AUD 292.9M 30.1M Jun/2025
CSL USD 1.96B 1.27B Jun/2025
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Nanosonics AUD 11.36M 2.36M Dec/2024
Polynovo AUD 2.86M 1.12M Jun/2024
Ramsay Health Care AUD 1.11B 84.1M Jun/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Telix Pharmaceuticals AUD 33.24M 6.5M Jun/2025